New Report Shows that Despite Gains, Black Americans Still Face Higher Cardiovascular Mortality
Between 2000 and 2022, there were nearly 800 000 excess CV deaths among Black Americans and 24 million additional years of life lost, researchers report.
ADA Standards of Care in Diabetes 2024: A Guideline Topline
For primary care clinicians, this Guideline Topline provides a summary of 2024 ADA Standard of Care updates that may support improved outcomes in your practice.
Dapagliflozin Approved by FDA to Improve Glycemic Control in Children, Adolescents with T2D
Among youth aged 10 to 17 years with uncontrolled hyperglycemia dapagliflozin led to a statistically significant reduction in A1c vs placebo in the T2NOW phase 3 clinical trial.
Can Clinician Empathy Affect Chronic Pain?
A clinician's empathy during a clinic encounter with a person with chronic pain can have a statistically significant impact on outcomes, a new study found.
Investigational RNAi Agent Cuts Triglyceride Levels in Patients with Mixed Hyperlipidemia: Daily Dose
Your daily dose of the clinical news you may have missed.
FDA Approves Merck's 21-Valent Pneumococcal Vaccine for Adults 50 Years of Age and Older: A First and Long-Awaited
Capvaxive is the only pneumococcal vaccine formulated specifically to protect adults 50 years and older from IPD and elicited robust immune responses in both vaccine-naïve and vaccine-experienced adults.
Defining Long COVID: Highlights from the National Academy of Sciences Consensus Report
In part the National Academies describe long COVID as "a chronic, systemic disease state with profound consequences." The report provides a working definition.
ADA 84th Scientific Sessions Preview: STEP-HFp-EF Trial Data, Tirzepatide for Obesity-Related OSA, Optimizing Diabetes Care in Primary Care
Find details on optimizing diabetes care in primary care settings, benefits of GLP-1RAs for patients with HF and diabetes, and tirzepatide use for obesity-related OSA.
Tirzepatide Superior to Placebo in MASH Resolution, Fibrosis Improvement: Daily Dose
Type 1 Diabetes in Older Adults Nearly Tripled in 3 Decades, According to New Data
Global prevalence of adults 65 years and older with T1D increased 180% in the past 30 years, researchers reported.
Adolescent Obesity Linked to Higher Stroke Risk in Women: Daily Dose
Mifepristone Access Upheld by US Supreme Court
The unanimous ruling maintains nationwide access to mifepristone for medical abortion, reversing a lower court's decision to restrict availability.
Tirzepatide Found Superior to Placebo in MASH Resolution, Fibrosis Improvement
More than 50% of patients with MASH receiving 1 of 3 doses of tirzepatide achieved MASH resolution without worsening of fibrosis vs placebo, according to data from phase 2 study.
US Drug Overdose Deaths Declined for First Time in 5 Years: Daily Dose
Phase III Trials Show Depemokimab Reduces Severe Asthma Exacerbations with Twice-Yearly Dosing
The high potency IL-5 inhibitor can be administered every 6 months, offering a convenient alternative to other biologic agents for appropriate patients with severe asthma.
FDA Grants EUA for OTC Triple Test for COVID-19, Influenza A & B: Daily Dose
Sugar Alcohol Xylitol Associated with Increased Risk of MACE: Cleveland Clinic Research
As xylitol is used increasingly to replace sugar in an array of food and other products, Clinic reselinic researchers call for increased scientific scrutiny rchers call for increased scrutiny..
Women with Overweight/Obesity as Teens, Young Adults Face Higher Risk of Cerebrovascular Disease Later in Life
In contrast, men did not face the same increased risk of cerebrovascular disease later in life, reported authors of a new study.
Two Medication Classes Reduce CV, Liver Events in Persons with T2D, MASLD: Daily Dose
UPDATE 6-11-2024: Eisai Files sBLA for Lecanemab-irmb Maintenance Dosing
The FDA has assigned a PDUFA action date of January 25, 2025 for the monthly IV maintenance dose.
